CHO Pharma, Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was TWD 162.25 million compared to TWD 110.92 million a year ago. Basic loss per share from continuing operations was TWD 0.88 compared to TWD 0.6 a year ago. Diluted loss per share from continuing operations was TWD 0.88 compared to TWD 0.6 a year ago.